News

Actoverco Pharmaceutical Company

Selected News

4R4A5641-1-2048x1365

Actover Pharmaceutical Group Participates in the 10th IRAN PHARMA Exhibition

4R4A3136-2048x1365 (1)

Actoverco Medical Director Stated: A Strong Commitment to the “Pharmacovigilance” System Ensures the Safety and Reliability of Actover Products

M_HA18361-2048x1365

Actover Group Unveils “Zeponim” for the Management of Multiple Sclerosis and Ulcerative Colitis

nexus23

Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025

4R4A0525

Actover Pharmaceutical Group Showcases Its Neurology Portfolio at the 32nd Iranian Congress of Neurology and Clinical Electrophysiology

Four great achievements

efforts of the children of Iran in the Actover Pharmaceutical Group, four great achievements in the current situation are presented as a drop from the boundless sea of service to the noble people of our country.

Actoverco’s attendance at 19th Annual Congress of Iranian Society of Dermatology

19th  Annual Congress of Iranian Society of Dermatology was held in 15-17 January 2020 at Olympic Hotel.

Unveiling of 3 new drugs of Actoverco Company among the neurology group

On December 26, 2019, during a glorious ceremony attended by more than 180 psychiatrists and neurologists, three new drugs of Actoverco Company were officially unveiled.

Actoverco’s attendance at the 17th International Congress of Iranian Society of Nephrology

The 17th International Congress of Nephrology, Dialysis and Kidney Transplantation of the Iranian Society of Nephrology was held in collaboration with the International Nephrology Association and Tabriz University of Medical Sciences, from 19-22 November 2019 at Tabriz University of Medical Sciences.

World Diabetes Day

23rd Aban (14th November) is the World Diabetes Day.

The purpose of this day’s naming was the awareness increment about diabetes, especially type 2, as one of the most common non-communicable preventable and treatable disease.

Actoverco’s attendance at the 9th Seminar on Evidence-Based Medicine of Dermatology, Cosmetic and Laser and the 5th Razi Dermatology Residency Congress

Razi Hospital Annual Dermatology Congress and the 9th Seminar on Evidence-Based Medicine of Dermatology, Cosmetic and Laser were held jointly for the first time on November 13-15 at the Olympic Hotel in Tehran.

Actoverco’s attendance at the 16th International MS Congress

The 16th International MS Congress was held in Holy Mashhad on 13 to 15 November by the Razavi Khorasan MS Association in collaboration with the Department of Neurology of Ghaem…

Actoverco’s attendance at the 19th Iranian Congress of Gastroenterology and Hepatology

The 19th Iranian Congress of Gastroenterology and Hepatology was held from November 6 to 8 at the Razi International Conference Center.

Actero Middle East’s attendance in the 18th Congress of the Iranian Society of Medical Oncology and Hematology

The 18th National Congress of the Oncology and Hematology Society and the Cancer Nursing Conference were held from November 14th to 16th, 2019 at the Evin Hotel in Tehran.

Appreciation of the sacrificers (Isargar) working in Actoverco Company

On the occasion of Arba’een, 150 sacrificers (Isargar) working in the Actover group were appreciated and honored

9th International Congress on Pulmonary disease, Intensive Care and Tuberculosis

The 9th International Congress on Pulmonary disease, Intensive Care and Tuberculosis was held by Dr. Masih Daneshvari Medical Center at Farhikhtegan Hospital in Tehran on October 12-15, 2019.

Actoverco’s attendance at the 3rd international Razavi cardiovascular congress (Caspian and CTO)

The 3rd international Razavi cardiovascular congress was held in Razavi Hospital from 9 to 11 October 2019 for 3 days